F · Healthcare

ABEONA THERAPEUT. DL-01 (PCJ)

Biotechnology

ABEONA THERAPEUT. DL-01 (PCJ) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $212.22M, P/E ratio is 4.23, net margin is 1,223.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PCJ

Market cap

$212.22M

P/E ratio

4.23

Gross profit (TTM)

$-24.42M

Net margin

1,223.1%

ABEONA THERAPEUT. DL-01 (PCJ) — FAQ

What is ABEONA THERAPEUT. DL-01's market cap?

ABEONA THERAPEUT. DL-01 (PCJ) has a reported market cap of $212.22M (data as of 2026-03-30).

What is PCJ's P/E ratio?

The price-to-earnings (P/E) ratio for ABEONA THERAPEUT. DL-01 (PCJ) is 4.23 (data as of 2026-03-30).

Does ABEONA THERAPEUT. DL-01 pay a dividend?

Dividend yield is not available in the current snapshot for ABEONA THERAPEUT. DL-01 (PCJ). Check the MyAverix Finance app for the latest dividend data.

What sector is ABEONA THERAPEUT. DL-01 in?

ABEONA THERAPEUT. DL-01 (PCJ) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PCJ listed on?

PCJ is listed on F.

What is ABEONA THERAPEUT. DL-01's net margin?

ABEONA THERAPEUT. DL-01 (PCJ) reports a net margin of 1,223.1% (data as of 2026-03-30).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Aimed Bio (0009K0) Celltrion (068270) Rznomics (476830)